Antibiotic combination therapy in patients with chronic, treatment‐resistant pouchitis

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2036.1999.00553.xPMID 10383499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

  1999cited by this paper
• A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease

  1999cited by this paper
• Pouchitis: Risk Factors, Etiology, and Treatment

  1998cited by this paper
• Rifaximin systemic absorption in patients with ulcerative colitis

  1998cited by this paper
• Long‐term efficacy of bismuth carbomer enemas in patients with treatment‐resistant chronic pouchitis

  1997cited by this paper
• Ileo-anal pouch function and dysfunction.

  1997cited by this paper
• Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double‐blind, placebo‐controlled trial

  1997cited by this paper
• Review article: the management of pouchitis.

  1996cited by this paper
• An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.

  1996cited by this paper
• the management of pouchitis

  1996cited by this paper
• Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.

  1996cited by this paper
• Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria.

  1995cited by this paper
• Pharmacokinetic study of rifaximin after oral administration in healthy volunteers.

  1994cited by this paper
• Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis

  1994cited by this paper
• Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

  1994cited by this paper
• Pouchitis following heal pouch-anal anastomosis: Definition, pathogenesis, and treatment

  1994cited by this paper
• Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment.

  1994cited by this paper
• Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.

  1993cited by this paper
• Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis

  1993cited by this paper
• Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch.

  1993cited by this paper
• Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes.

  1993cited by this paper
• Ciprofloxacin-induced vasculitis.

  1989cited by this paper
• Topical administration of 5-aminosalicylic acid: a therapeutic proposal for the treatment of pouchitis.

  1989cited by this paper
• Topical administration of 5-aminosalicylic acid: a therapeutic proposal for the treatment of pouchitis.

  1989cited by this paper
• Pouchitis.

  1989cited by this paper
• Ileal Pouch‐Anal Anastomosis for Chronic Ulcerative Colitis: Long‐term Results

  1987cited by this paper
• In vitro and in vivo evaluation of L/105, a new topical intestinal rifamycin.

  1986cited by this paper
• Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets

  1986cited by this paper
• Restorative proctocolectomy with ileal reservoir

  1985cited by this paper
• Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

  1984cited by this paper
• [Long-term results].

  1983cited by this paper

• Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study

  2025cites this paper
• Recurrent Pouchitis Uncovering De Novo Celiac Disease

  2025cites this paper
• Managing Pouchitis: Where do Antibiotics End, and Advanced Therapies Begin?

  2025cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2)

  2024cites this paper
• A fekélyes vastagbélgyulladás gyógyszeres és sebészeti kezelése

  2024cites this paper
• The aetiology of pouchitis in patients with inflammatory bowel disease

  2024cites this paper
• Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU

  2024cites this paper
• Diagnosis and Medical Treatment of Acute and Chronic Idiopathic Pouchitis in Inflammatory Bowel Disease

  2024cites this paper
• Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis

  2024cites this paper
• Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders—A Systematic Review and Meta-Analysis

  2024cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009

  2023cites this paper
• A Systematic Review and Meta-analysis of Randomized Clinical Trials on the Prevention and Treatment of Pouchitis after Ileoanal Pouch Anastomosis

  2023cites this paper
• A metagenomic analysis for combination therapy of multiple classes of antibiotics on the prevention of the spread of antibiotic-resistant genes

  2023cites this paper
• CEG_A_219556 277..290

  2021cites this paper
• Chronic Antibiotic-Refractory Pouchitis: Management Challenges

  2021cites this paper
• Antibiotics in pediatric inflammatory bowel diseases: a systematic review

  2021cites this paper
• ECCO topical review: Refractory IBD.

  2021cites this paper
• Pouchitis: Clinical Features, Diagnosis, and Treatment

  2021cites this paper
• Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.

  2021cites this paper
• Pouchitis

  2020cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline

  2020cites this paper
• Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la reservoritis en la colitis ulcerosa. Parte 2: Tratamiento

  2020cites this paper
• Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment

  2020cites this paper
• Learning from Chemical Coping Behaviors of Wildlife to Discover New Approaches for Pest Management

  2020cites this paper
• An Update on the Medical Management of Inflammatory Pouch Complications.

  2020cites this paper
• Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.

  2020cites this paper
• Medical Treatment of Pouchitis

  2019cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa

  2019cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa

  2019cites this paper
• Long-term Complications after Surgical Treatment of Ulcerative Colitis

  2019cites this paper
• Antibiotics and probiotics in inflammatory bowel disease: when to use them?

  2019cites this paper
• Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience

  2019cites this paper
• Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS)

  2019cites this paper
• The Role of Biomarkers in the Ileal Anal Pouch

  2019cites this paper
• Management of Chronic Pouchitis

  2019cites this paper
• Endoscopy in Postoperative Patients with Crohn's Disease or Ulcerative Colitis. Does It Translate to Better Outcomes?

  2019cites this paper
• Prevention And Medical Treatment Of Pouchitis In Ulcerative Colitis.

  2019cites this paper
• Management of de Novo Crohn’s Disease after Reconstructive Surgery with Continent Ileostomy in Ulcerative Colitis

  2018cites this paper
• A Comprehensive Approach to Pouch Disorders.

  2018cites this paper
• Aktualisierte S3-Leitlinie Colitis ulcerosa der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

  2018cites this paper
• TITLE: Prolonged Antibiotic Treatment Generates a Fluoroquinolone Resistant Gut Microbiome

  2018cites this paper
• Long-term follow-up of the use of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis

  2018cites this paper
• Neoterminal Ileal Polyposis and Ulceration after Restorative Proctocolectomy with a Current Review of the Literature

  2018cites this paper
• The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease

  2018cites this paper
• Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis

  2018cites this paper
• Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study

  2018cites this paper
• Prolonged Antibiotic Treatment Generates a Fluoroquinolone Resistant Gut Microbiome and Collateral Multi-Drug Resistance

  2018cites this paper
• Management of Pouchitis and Other Common Complications of the Pouch.

  2018cites this paper
• Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.

  2017cites this paper
• Probiotics, Prebiotics, and Antibiotics in IBD

  2017cites this paper
• Treatment of chronic and refractory pouchitis

  2017cites this paper
• Comment je traite une pochite ?

  2017cites this paper
• Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches.

  2017cites this paper
• Systematic review with meta‐analysis: the management of chronic refractory pouchitis with an evidence‐based treatment algorithm

  2017cites this paper
• Validated Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometric Method for Quantification of Milnacipranin Human Plasma for Pharmacokinetic Study: ARandomized, Open-Label, Two-Period, Comparative Crossover Study in Healthy Korean Male Volunteers

  2016cites this paper
• Advanced Vaccine Research Methods for the Decade of Vaccines

  2016influential citation
• Engineering the Microbiome: a Novel Approach to Immunotherapy for Allergic and Immune Diseases

  2015cites this paper
• [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)].

  2015cites this paper
• Role of Endoscopy to Define Postoperative Recurrence in IBD

  2015cites this paper
• The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis

  2015cites this paper
• Role of Rifaximin in Inflammatory Bowel Disease Treatment.

  2015cites this paper
• Surgical Principles in the Treatment of Ulcerative Colitis

  2015cites this paper
• Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis

  2015cites this paper
• Association between specific mucosa‐associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study

  2015cites this paper
• Polymyxin Combinations against Pseudomonas aeruginosa : Profiling the Time-Course of Synergistic Killing and Prevention of Resistance

  2015cites this paper
• Use of Biologics in Pouchitis: A Systematic Review

  2015cites this paper
• Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches

  2015cites this paper
• Oral beclomethasone dipropionate in chronic refractory pouchitis.

  2014cites this paper
• Role of probiotics in the management of pouchitis.

  2014cites this paper
• Management of Acute and Chronic Pouchitis

  2014cites this paper
• Current Status and Prospects of Intestinal Microbiome Studies

  2014cites this paper
• Probiotics, Prebiotics, and Antibiotics for Ulcerative Colitis

  2014cites this paper
• Role of Intestinal Bacteria in the Pathogenesis of Pouchitis

  2014cites this paper
• Probiotics and Antibiotics in IBD

  2014cites this paper
• Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens

  2013cites this paper
• What Every Gastroenterologist Needs to Know

  2013cites this paper
• Considerations and complications in patients undergoing ileal pouch anal anastomosis.

  2013cites this paper
• Effect of Fluoroquinolone Resistance Selection on the Fitness of Three Strains of Clostridium perfringens

  2013cites this paper
• Rationale for the use of rifaximin in inflammatory bowel diseases based on clinical trial results

  2013cites this paper
• Pouchitis: what every gastroenterologist needs to know.

  2013cites this paper
• Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.

  2013cites this paper
• The Role of Anti(myco)bacterial Interventions in the Management of IBD: Is There Evidence at All?

  2012cites this paper
• Etiology of pouchitis*

  2012cites this paper
• Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease

  2012cites this paper
• Ruolo della terapia immunosoppressiva e biologica nelle IBD pediatriche

  2012cites this paper
• Diagnosis and Treatment of Patients with Pouchitis

  2012cites this paper
• Randomized controlled trials in pouchitis.

  2012cites this paper
• Pouchitis: a practical guide

  2012cites this paper
• The role of antibiotics and probiotics in pouchitis

  2012cites this paper
• Dealing with Pouchitis

  2012cites this paper
• Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease

  2012cites this paper
• Bacterial flora as a cause or treatment of chronic diarrhea.

  2012cites this paper
• Probable rifaximin-induced neutropenia.

  2012cites this paper
• Acute and chronic pouchitis—pathogenesis, diagnosis and treatment

  2012cites this paper
• Probiotics, Prebiotics, and Antibiotics in Medical Management of Inflammatory Bowel Disease

  2012cites this paper
• Optimization of conventional therapy in patients with IBD

  2011cites this paper
• How to manage pouchitis in ulcerative colitis?

  2011cites this paper
• Transmural inflammation is not pathognomonic for Crohn’s disease of the pouch

  2011cites this paper
• Rifaximin in the treatment of inflammatory bowel disease.

  2011cites this paper
• Molecular Analysis Reveals Unique Microbiome in Ileal Pouch During Pouchitis Compared to Healthy Pouches in Ulcerative Colitis and Familial Adenomatous Polyposis

  2011cites this paper